Browse > Article
http://dx.doi.org/10.5125/jkaoms.2020.46.5.301

Salivary biomarkers in oral squamous cell carcinoma  

Nguyen, Truc Thi Hoang (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University)
Sodnom-Ish, Buyanbileg (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University)
Choi, Sung Weon (Oral Oncology Clinic, Research Institute & Hospital, National Cancer Center)
Jung, Hyo-Il (School of Mechanical Engineering, Yonsei University)
Cho, Jaewook (R&D Center, InSol Co.)
Hwang, Inseong (R&D Center, InSol Co.)
Kim, Soung Min (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.46, no.5, 2020 , pp. 301-312 More about this Journal
Abstract
In disease diagnostics and health surveillance, the use of saliva has potential because its collection is convenient and noninvasive. Over the past two decades, the development of salivary utilization for the early detection of cancer, especially oral cavity and oropharynx cancer has gained the interest of the researcher and clinician. Until recently, the oral cavity and oropharynx cancers are still having a five-year survival rate of 62%, one of the lowest in all major human cancers. More than 90% of oral cancers are oral squamous cell carcinoma (OSCC). Despite the ease of accessing the oral cavity in clinical examination, most OSCC lesions are not diagnosed in the early stage, which is suggested to be the main cause of the low survival rate. Many studies have been performed and reported more than 100 potential saliva biomarkers for OSCC. However, there are still obstacles in figuring out the reliable OSCC salivary biomarkers and the clinical application of the early diagnosis protocol. The current review article discusses the emerging issues and is hoped to raise awareness of this topic in both researchers and clinicians. We also suggested the potential salivary biomarkers that are reliable, specific, and sensitive for the early detection of OSCC.
Keywords
Squamous cell carcinoma of head and neck; Mouth neoplasm; Saliva; Biomarkers;
Citations & Related Records
연도 인용수 순위
  • Reference
1 St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:929-35. https://doi.org/10.1001/archotol.130.8.929   DOI
2 Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, Chia D, et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis 2008;14:705-12. https://doi.org/10.1111/j.1601-0825.2008.01488.x   DOI
3 Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD, Rehman IU. Role of salivary biomarkers in oral cancer detection. Adv Clin Chem 2018;86:23-70. https://doi.org/10.1016/bs.acc.2018.05.002   DOI
4 de Jong EP, Xie H, Onsongo G, Stone MD, Chen XB, Kooren JA, et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One 2010;5:e11148. https://doi.org/10.1371/journal.pone.0011148   DOI
5 Wang Q, Gao P, Wang X, Duan Y. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta 2014;427:79-85. https://doi.org/10.1016/j.cca.2013.10.004   DOI
6 Camisasca DR, da Ros Goncalves L, Soares MR, Sandim V, Nogueira FC, Garcia CH, et al. A proteomic approach to compare saliva from individuals with and without oral leukoplakia. J Proteomics 2017;151:43-52. https://doi.org/10.1016/j.jprot.2016.07.029   DOI
7 Flores IL, Santos-Silva AR, Coletta RD, Leme AF, Lopes MA. Low expression of angiotensinogen and dipeptidyl peptidase 1 in saliva of patients with proliferative verrucous leukoplakia. World J Clin Cases 2016;4:356-63. https://doi.org/10.12998/wjcc.v4.i11.356   DOI
8 Hu S, Arellano M, Boontheung P, Wang J, Zhou H, Jiang J, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008;14:6246-52. https://doi.org/10.1158/1078-0432.CCR-07-5037   DOI
9 Almadori G, Bussu F, Galli J, Limongelli A, Persichilli S, Zappacosta B, et al. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. Head Neck 2007;29:648-54. https://doi.org/10.1002/hed.20579   DOI
10 Jou YJ, Lin CD, Lai CH, Chen CH, Kao JY, Chen SY, et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chim Acta 2010;681:41-8. https://doi.org/10.1016/j.aca.2010.09.030   DOI
11 Katakura A, Kamiyama I, Takano N, Shibahara T, Muramatsu T, Ishihara K, et al. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll 2007;48:199-203. https://doi.org/10.2209/tdcpublication.48.199   DOI
12 Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer 2008;113:750-7. https://doi.org/10.1002/cncr.23615   DOI
13 Zhong LP, Chen GF, Xu ZF, Zhang X, Ping FY, Zhao SF. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg 2005;34:566-70. https://doi.org/10.1016/j.ijom.2004.10.007   DOI
14 Krishna Prasad RB, Sharma A, Babu HM. An insight into salivary markers in oral cancer. Dent Res J (Isfahan) 2013;10:287-95.
15 Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007;16:1348-55. https://doi.org/10.1158/1055-9965.EPI-06-0011   DOI
16 Kumar M, Srivastava G, Kaur J, Assi J, Alyass A, Leong I, et al. Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients. J Transl Med 2015;13:8. https://doi.org/10.1186/s12967-014-0369-9   DOI
17 Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10:8442-50. https://doi.org/10.1158/1078-0432.CCR-04-1167   DOI
18 Righini CA, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 2007;13:1179-85. https://doi.org/10.1158/1078-0432.CCR-06-2027   DOI
19 Reddy I, Sherlin HJ, Ramani P, Premkumar P, Natesan A, Chandrasekar T. Amino acid profile of saliva from patients with oral squamous cell carcinoma using high performance liquid chromatography. J Oral Sci 2012;54:279-83. https://doi.org/10.2334/josnusd.54.279   DOI
20 Al Kawas S, Rahim ZH, Ferguson DB. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. Arch Oral Biol 2012;57:1-9. https://doi.org/10.1016/j.archoralbio.2011.06.013   DOI
21 Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev 2012;2:664-72. https://doi.org/10.1158/1055-9965.EPI-11-1093
22 Tang H, Wu Z, Zhang J, Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep 2013;7:761-6. https://doi.org/10.3892/mmr.2012.1254   DOI
23 Liu CJ, Lin SC, Yang CC, Cheng HW, Chang KW. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 2012;34:219-24. https://doi.org/10.1002/hed.21713   DOI
24 Park NJ, Zhou H, Elashoff D, Henson BS, Kastratovic DA, Abemayor E, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009;15:5473-7. https://doi.org/10.1158/1078-0432.CCR-09-0736   DOI
25 Feng Y, Li Q, Chen J, Yi P, Xu X, Fan Y, et al. Salivary protease spectrum biomarkers of oral cancer. Int J Oral Sci 2019;11:7. https://doi.org/10.1038/s41368-018-0032-z   DOI
26 Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 2011;129:2207-17. https://doi.org/10.1002/ijc.25881   DOI
27 Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics 2010;6:78-95. https://doi.org/10.1007/s11306-009-0178-y   DOI
28 Ishikawa S, Sugimoto M, Kitabatake K, Sugano A, Nakamura M, Kaneko M, et al. Identification of salivary metabolomic biomarkers for oral cancer screening. Sci Rep 2016;6:31520. https://doi.org/10.1038/srep31520   DOI
29 Peng M, Chen C, Hulbert A, Brock MV, Yu F. Non-blood circulating tumor DNA detection in cancer. Oncotarget 2017;8:69162-73. https://doi.org/10.18632/oncotarget.19942   DOI
30 Zhang CZ, Cheng XQ, Li JY, Zhang P, Yi P, Xu X, et al. Saliva in the diagnosis of diseases. Int J Oral Sci 2016;8:133-7. https://doi.org/10.1038/ijos.2016.38   DOI
31 Grobe A, Blessmann M, Hanken H, Friedrich RE, Schon G, Wikner J, et al. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity. Clin Cancer Res 2014;20:425-33. https://doi.org/10.1158/1078-0432.CCR-13-1101   DOI
32 Bhattarai KR, Kim HR, Chae HJ. Compliance with saliva collection protocol in healthy volunteers: strategies for managing risk and errors. Int J Med Sci 2018;15:823-31. https://doi.org/10.7150/ijms.25146   DOI
33 Golatowski C, Salazar MG, Dhople VM, Hammer E, Kocher T, Jehmlich N, et al. Comparative evaluation of saliva collection methods for proteome analysis. Clin Chim Acta 2013;419:42-6. https://doi.org/10.1016/j.cca.2013.01.013   DOI
34 Cabras T, Pisano E, Boi R, Olianas A, Manconi B, Inzitari R, et al. Age-dependent modifications of the human salivary secretory protein complex. J Proteome Res 2009;8:4126-34. https://doi.org/10.1021/pr900212u   DOI
35 Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694:72-7. https://doi.org/10.1111/j.1749-6632.1993.tb18343.x   DOI
36 Yoshizawa JM, Schafer CA, Schafer JJ, Farrell JJ, Paster BJ, Wong DT. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev 2013;26:781-91. https://doi.org/10.1128/CMR.00021-13   DOI
37 Nassar M, Hiraishi N, Islam S, Otsuki M, Tagami J. Age-related changes in salivary biomarkers. J Dent Sci 2014;9:85-90. https://doi.org/10.1016/j.jds.2013.11.002   DOI
38 Fenoll-Palomares C, Munoz Montagud JV, Sanchiz V, Herreros B, Hernandez V, Minguez M, et al. Unstimulated salivary flow rate, pH and buffer capacity of saliva in healthy volunteers. Rev Esp Enferm Dig 2004;96:773-83. https://doi.org/10.4321/s1130-01082004001100005
39 Chiappin S, Antonelli G, Gatti R, De Palo EF. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 2007;383:30-40. https://doi.org/10.1016/j.cca.2007.04.011   DOI
40 Henson BS, Wong DT. Collection, storage, and processing of saliva samples for downstream molecular applications. Methods Mol Biol 2010;666:21-30. https://doi.org/10.1007/978-1-60761-820-1_2   DOI
41 Shirtcliff EA, Granger DA, Schwartz E, Curran MJ. Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology 2001;26:165-73. https://doi.org/10.1016/s0306-4530(00)00042-1   DOI
42 Williamson S, Munro C, Pickler R, Grap MJ, Elswick RK Jr. Comparison of biomarkers in blood and saliva in healthy adults. Nurs Res Pract 2012;2012:246178. https://doi.org/10.1155/2012/246178   DOI
43 Aziz NZ, Arathi K, Prasad BG, Desai D, Shetty SJ, Shahid M. Evaluation of magnesium levels in blood and saliva of oral squamous cell carcinoma and potentially malignant disorders by xylidyl blue method. J Oral Maxillofac Pathol 2018;22:147. https://doi.org/10.4103/jomfp.JOMFP_34_17
44 Ngamchuea K, Batchelor-McAuley C, Cowen PJ, Williams C, Goncalves LM, Compton RG. Can saliva testing replace blood measurements for health monitoring? Insights from a correlation study of salivary and whole blood glutathione in humans. Analyst 2016;14:4707-12. https://doi.org/10.1039/c6an01139j
45 Sharma M, Sharma E, Prabhu V, Pai VR, D'souza JM, Harish S, et al. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer. J Cancer Res Ther 2020;16:546-50. https://doi.org/10.4103/jcrt.JCRT_552_17   DOI
46 Singh P, Barpande SR, Bhavthankar JD, Mandale MS, Bhagwat AU. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation. Indian J Dent Res 2017;28:162-8. https://doi.org/10.4103/0970-9290.207789   DOI
47 Metgud R, Patel S. Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy. Biotech Histochem 2014;89:8-13. https://doi.org/10.3109/10520295.2013.793394   DOI
48 Ai J, Smith B, Wong DT. Saliva ontology: an ontology-based framework for a Salivaomics knowledge base. BMC Bioinformatics 2010;11:302. https://doi.org/10.1186/1471-2105-11-302   DOI
49 Wu CC, Chu HW, Hsu CW, Chang KP, Liu HP. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma. Proteomics 2015;15:3394-404. https://doi.org/10.1002/pmic.201500157   DOI
50 Flannery CR. MMPs and ADAMTSs: functional studies. Front Biosci 2006;11:544-69. https://doi.org/10.2741/1818   DOI
51 Conway DI, Purkayastha M, Chestnutt IG. The changing epidemiology of oral cancer: definitions, trends, and risk factors. Br Dent J 2018;225:867-73. https://doi.org/10.1038/sj.bdj.2018.922   DOI
52 Kim JM, Kang SW, Shin SM, Su Kim D, Choi KK, Kim EC, et al. Inhibition of matrix metalloproteinases expression in human dental pulp cells by all-trans retinoic acid. Int J Oral Sci 2014;6:150-3. https://doi.org/10.1038/ijos.2013.63   DOI
53 Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008;29:258-89. https://doi.org/10.1016/j.mam.2008.08.001   DOI
54 Chu HW, Chang KP, Hsu CW, Chang IY, Liu HP, Chen YT, et al. Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches. Mol Cell Proteomics 2019;18:1796-806. https://doi.org/10.1074/mcp.RA119.001530   DOI
55 Mishra A, Verma M. Cancer biomarkers: are we ready for the prime time? Cancers (Basel) 2010;2:190-208. https://doi.org/10.3390/cancers2010190   DOI
56 Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 2017;67:51-64. https://doi.org/10.3322/caac.21384   DOI
57 Patel RS, Clark JR, Dirven R, Wyten R, Gao K, O'Brien CJ. Prognostic factors in the surgical treatment of patients with oral carcinoma. ANZ J Surg 2009;79:19-22. https://doi.org/10.1111/j.1445-2197.2008.04791.x   DOI
58 Gupta N, Gupta R, Acharya AK, Patthi B, Goud V, Reddy S, et al. Changing Trends in oral cancer - a global scenario. Nepal J Epidemiol 2016;6:613-9. https://doi.org/10.3126/nje.v6i4.17255   DOI
59 Johnson NW, Jayasekara P, Amarasinghe AA. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000 2011;57:19-37. https://doi.org/10.1111/j.1600-0757.2011.00401.x   DOI
60 Ilbawi AM, Anderson BO. Cancer in global health: how do prevention and early detection strategies relate? Sci Transl Med 2015;7:278. https://doi.org/10.1126/scitranslmed.3008853
61 Lousada-Fernandez F, Rapado-Gonzalez O, Lopez-Cedrun JL, Lopez-Lopez R, Muinelo-Romay L, Suarez-Cunqueiro MM. Liquid biopsy in oral cancer. Int J Mol Sci 2018;19:1704. https://doi.org/10.3390/ijms19061704   DOI
62 Kaczor-Urbanowicz KE, Martin Carreras-Presas C, Aro K, Tu M, Garcia-Godoy F, Wong DT. Saliva diagnostics - current views and directions. Exp Biol Med (Maywood) 2017;245:459-72. https://doi.org/10.1177/1535370216681550
63 Cheng YS, Rees T, Wright J. A review of research on salivary biomarkers for oral cancer detection. Clin Transl Med 2014;3:3. https://doi.org/10.1186/2001-1326-3-3   DOI
64 Thomadaki K, Helmerhorst EJ, Tian N, Sun X, Siqueira WL, Walt DR, et al. Whole-saliva proteolysis and its impact on salivary diagnostics. J Dent Res 2011;90:1325-30. https://doi.org/10.1177/0022034511420721   DOI
65 Arglebe C. Biochemistry of human saliva. Adv Otorhinolaryngol 1981;26:97-234. https://doi.org/10.1159/000395291
66 Hu S, Loo JA, Wong DT. Human saliva proteome analysis and disease biomarker discovery. Expert Rev Proteomics 2007;4:531-8. https://doi.org/10.1586/14789450.4.4.531   DOI
67 Wong DT. Salivaomics. J Am Dent Assoc 2012;143(10 Suppl):19S-24S. https://doi.org/10.14219/jada.archive.2012.0339   DOI
68 Tachibana M, Tonomoto Y, Hyakudomi R, Hyakudomi M, Hattori S, Ueda S, et al. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma. Dig Liver Dis 2007;39:725-32. https://doi.org/10.1016/j.dld.2007.05.013   DOI
69 Shpitzer T, Hamzany Y, Bahar G, Feinmesser R, Savulescu D, Borovoi I, et al. Salivary analysis of oral cancer biomarkers. Br J Cancer 2009;101:1194-8. https://doi.org/10.1038/sj.bjc.6605290   DOI
70 Rajkumar K, Ramesh Kumar A, Ramyamalini V, Nandhini G, Dinesh Kumar T, Ashwini BK, et al. Estimation of serological and salivary biomarkers in patients vith oral squamous cell carcinoma, premalignant lesions & conditions. SRM J Res Dent Sci 2010;1:14-9.